Cross-serotype immunity elicited by a consensus dengue NS1 mRNA vaccine in mice
Kittipan Tharakhet, Eakachai Prompetchara, Chirayus Khawsang, Supichcha Saithong, Papatsara Kaewpang, Nongnaphat Yostrerat, Pachara Wangsoontorn, Jenjira Sontikun · 2026
Read Cross-serotype immunity elicited by a consensus dengue NS1 mRNA vaccine in mice by Kittipan Tharakhet, Eakachai Prompetchara, Chirayus Khawsang, Supichcha Saithong, Papatsara Kaewpang, Nongnaphat Yostrerat, Pachara Wangsoontorn, Jenjira Sontikun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355389.txt.
Description
Kittipan Tharakhet and colleagues test in 2026 a messenger RNA vaccine in mice aimed at all four types of dengue virus at once. Four distinct types make dengue hard to vaccinate against, since protection must cover each one. Their design blends parts of a viral protein from every type into one shared version, packed into tiny fat droplets for delivery.
Even a low dose raised antibodies that recognised the protein from all four types. Immune cells also reacted to pieces from several types, though each single type response was weaker than a focused vaccine might give. The authors see the shared design as a useful addition to future dengue vaccines.
Catalog record
| CREATOR | Kittipan Tharakhet, Eakachai Prompetchara, Chirayus Khawsang, Supichcha Saithong, Papatsara Kaewpang, Nongnaphat Yostrerat, Pachara Wangsoontorn, Jenjira Sontikun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32750 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |